These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21366498)

  • 1. B cell depletion in autoimmune diabetes: insights from murine models.
    Chamberlain JL; Attridge K; Wang CJ; Ryan GA; Walker LS
    Expert Opin Ther Targets; 2011 Jun; 15(6):703-14. PubMed ID: 21366498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
    Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
    Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells and type 1 diabetes ...in mice and men.
    Hinman RM; Smith MJ; Cambier JC
    Immunol Lett; 2014 Aug; 160(2):128-32. PubMed ID: 24472603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
    Baumann EE; Buckingham F; Herold KC
    Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity to islet cells: lessons from animal studies.
    Kolb H; Kiesel U; Flohr K; Greulich B; Freytag G; Kolb-Bachofen V
    Behring Inst Mitt; 1984 Jul; (75):33-8. PubMed ID: 6385952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice.
    Akashi T; Nagafuchi S; Anzai K; Kondo S; Kitamura D; Wakana S; Ono J; Kikuchi M; Niho Y; Watanabe T
    Int Immunol; 1997 Aug; 9(8):1159-64. PubMed ID: 9263013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis.
    Li Y; Sun F; Yue TT; Wang FX; Yang CL; Luo JH; Rong SJ; Xiong F; Zhang S; Wang CY
    Front Immunol; 2021; 12():690783. PubMed ID: 34335595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.
    Noorchashm H; Noorchashm N; Kern J; Rostami SY; Barker CF; Naji A
    Diabetes; 1997 Jun; 46(6):941-6. PubMed ID: 9166663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cell trafficking to the islets during type 1 diabetes.
    Sandor AM; Jacobelli J; Friedman RS
    Clin Exp Immunol; 2019 Dec; 198(3):314-325. PubMed ID: 31343073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotypes in T1D: B lymphocytes and early onset.
    Smith MJ; Cambier JC; Gottlieb PA
    Curr Opin Endocrinol Diabetes Obes; 2020 Aug; 27(4):225-230. PubMed ID: 32618634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic islet autoimmunity.
    Boitard C
    Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 18. T-B Lymphocyte Interactions Promote Type 1 Diabetes Independently of SLAM-Associated Protein.
    Bonami RH; Nyhoff LE; McNitt DH; Hulbert C; Felton JL; Kendall PL; Thomas JW
    J Immunol; 2020 Dec; 205(12):3263-3276. PubMed ID: 33199538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CD4
    Dwyer AJ; Ritz JM; Mitchell JS; Martinov T; Alkhatib M; Silva N; Tucker CG; Fife BT
    Sci Rep; 2021 Aug; 11(1):17142. PubMed ID: 34433860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.
    Pechhold K; Zhu X; Harrison VS; Lee J; Chakrabarty S; Koczwara K; Gavrilova O; Harlan DM
    Diabetes; 2009 May; 58(5):1175-84. PubMed ID: 19228810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.